Millennium Management’s Crinetics Pharmaceuticals CRNX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.27M Sell
62,368
-237,967
-79% -$10.6M ﹤0.01% 3755
2025
Q4
$14M Buy
300,335
+84,091
+39% +$3.74M 0.01% 1915
2025
Q3
$9.01M Sell
216,244
-141,433
-40% -$4.52M ﹤0.01% 2492
2025
Q2
$10.3M Buy
357,677
+350,989
+5,248% +$10.8M 0.01% 2226
2025
Q1
$224K Buy
+6,688
New +$250K ﹤0.01% 5252
2024
Q3
Sell
-43,184
Closed -$1.93M 6151
2024
Q2
$1.93M Sell
43,184
-221,827
-84% -$10.2M ﹤0.01% 3565
2024
Q1
$12.4M Sell
265,011
-108,618
-29% -$4.25M 0.01% 1990
2023
Q4
$13.3M Buy
373,629
+91,030
+32% +$2.79M 0.01% 1925
2023
Q3
$8.4M Buy
282,599
+240,071
+565% +$4.95M ﹤0.01% 2208
2023
Q2
$766K Sell
42,528
-52,279
-55% -$1.04M ﹤0.01% 4235
2023
Q1
$1.52M Sell
94,807
-480,681
-84% -$8.9M ﹤0.01% 3696
2022
Q4
$10.5M Buy
575,488
+253,736
+79% +$4.47M 0.01% 2072
2022
Q3
$6.32M Sell
321,752
-187,578
-37% -$3.83M ﹤0.01% 2663
2022
Q2
$9.5M Buy
509,330
+273,170
+116% +$5.45M 0.01% 2098
2022
Q1
$5.18M Buy
236,160
+203,201
+617% +$4.11M ﹤0.01% 2892
2021
Q4
$936K Buy
32,959
+20,847
+172% +$514K ﹤0.01% 4465
2021
Q3
$255K Buy
+12,112
New +$253K ﹤0.01% 5931
2021
Q1
Sell
-14,538
Closed -$205K 6003
2020
Q4
$205K Buy
+14,538
New +$202K ﹤0.01% 4794
2020
Q3
Sell
-113,034
Closed -$1.98M 4501
2020
Q2
$1.98M Buy
+113,034
New +$1.93M ﹤0.01% 2543
2020
Q1
Sell
-18,041
Closed -$453K 3942
2019
Q4
$453K Sell
18,041
-37,108
-67% -$706K ﹤0.01% 3447
2019
Q3
$829K Buy
+55,149
New +$1.07M ﹤0.01% 2960
2019
Q2
Sell
-8,888
Closed -$202K 4099
2019
Q1
$202K Buy
+8,888
New +$218K ﹤0.01% 3731

Other funds holding CRNX